1. Galárraga O, O’Brien ME, Gutierrez JP, Renaud-Thery F, Nguimfack BD, Beusenberg M, Waldman K, Soni A, Bertozzi SM, Greener R. Forecast of demand for antiretroviral drugs in low & middle-income countries: 2007-2008. AIDS 2007, 21 Suppl 4:S97-103.
2. Galárraga O, Bertozzi SM. Stakeholders’ opinions & expectations of the Global Fund & their potential economic implications. AIDS 2008, 22 Suppl 1:S7-S15.
3. DeMaria LM, Galárraga O, Campero L, Walker DM. Educación sobre sexualidad y prevención del VIH: un diagnóstico para América Latina y el Caribe. Revista Panamericana de Salud Pública 2009, 26(6):485-493.
4. Galárraga O, Colchero MA, Wamai RG, Bertozzi SM. HIV prevention cost-effectiveness: a systematic review. BMC Public Health 2009, 9 Suppl 1:S5.
5. Sosa-Rubí SG, Galárraga O, Harris JE. Heterogeneous impact of the “Seguro Popular” program on the utilization of obstetrical services in Mexico, 2001-2006: a multinomial probit model with a discrete endogenous variable. Journal of Health Economics 2009, 28(1):20-34.
6. Sosa-Rubí SG, Galárraga O, Lopez-Ridaura R. Diabetes treatment & control: the effect of public health insurance for the poor in Mexico. Bulletin of the World Health Organization 2009, 87(7):512-519.
7. Galárraga O, Salkever DS, Cook JA, Gange SJ. An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004. Health Economics 2010, 19(2):173-188.
8. Galárraga O, Sosa-Rubí SG, Salinas-Rodriguez A, Sesma-Vazquez S. Health insurance for the poor: impact on catastrophic & out-of-pocket health expenditures in Mexico. European Journal of Health Economics 2010, 11(5):437-447.
9. Rosales-Martinez Y*, Nigenda G, Galárraga O, Ruiz-Larios JA. [Migration expectations among nursing students in Mexico City]. Salud Pública de México 2010, 52(3):244-253.
10. Galárraga O, Wirtz VJ, Figueroa-Lara A*, Santa-Ana-Tellez Y*, Coulibaly I, Viisainen K, Medina-Lara A, Korenromp EL. Unit costs for delivery of ART & PMTCT of HIV: a systematic review for low- & middle-income countries. PharmacoEconomics 2011, 29(7):579-599.
11. Santa-Ana-Tellez Y*, DeMaria LM, Galárraga O. Costs of interventions for AIDS orphans & vulnerable children. Tropical Medicine & International Health 2011, 16(11):1417-1426.
12. Sosa-Rubí SG, Salinas-Rodriguez A, Galárraga O. Impacto del Seguro Popular en el gasto catastrófico y de bolsillo en el México rural y urbano, 2005–2008. Salud Pública de México 2011, 53 Suppl 4:425-435.
13. Thirumurthy H, Galárraga O, Larson B, Rosen S. HIV treatment produces economic returns through increased work & education, and warrants continued US support. Health Affairs 2012, 31(7):1470-1477.